Lakewood-Amedex Biotherapeutics, Inc.
LABT
$3.14
-$0.34-9.77%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -97.55% | -65.29% | -- | -- | -- |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -47.43% | -25.73% | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -90.82% | -60.54% | -- | -- | -- |
|
|
|||||
| Total Current Assets | -90.82% | -60.54% | -- | -- | -- |
| Net Property, Plant & Equipment | -46.75% | -41.65% | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -4.71% | -4.71% | -- | -- | -- |
| Total Assets | -76.00% | -55.02% | -- | -- | -- |
|
|
|||||
| Total Accounts Payable | 160.49% | 128.83% | -- | -- | -- |
| Total Accrued Expenses | 207.93% | 82.67% | -- | -- | -- |
| Short-term Debt | 712.50% | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 5.95% | 6.04% | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 296.92% | 380.44% | -- | -- | -- |
|
|
|||||
| Total Current Liabilities | 296.92% | 380.44% | -- | -- | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 712.50% | -- | -- | -- | -- |
| Capital Leases | -92.16% | -74.42% | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 239.78% | 270.06% | -- | -- | -- |
|
|
|||||
| Common Stock & APIC | 2.93% | 2.94% | -- | -- | -- |
| Retained Earnings | -8.46% | -7.77% | -- | -- | -- |
| Treasury Stock & Other | 0.00% | 0.00% | -- | -- | -- |
| Total Common Equity | -3,487.26% | -583.92% | -- | -- | -- |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 0.00% | 0.00% | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00% | 0.00% | -- | -- | -- |
|
|
|||||
| Total Common Equity | -3,487.26% | -583.92% | -- | -- | -- |
| Total Preferred Equity | 0.00% | 0.00% | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -3,629.13% | -579.61% | -- | -- | -- |
|
|
|||||